512 related articles for article (PubMed ID: 22924896)
21. Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain-differences between regional pharmacovigilance centres and pharmaceutical industry.
Fernandez-Fernandez C; Lázaro-Bengoa E; Fernández-Antón E; Quiroga-González L; Montero Corominas D
Eur J Clin Pharmacol; 2020 Aug; 76(8):1175-1181. PubMed ID: 32447435
[TBL] [Abstract][Full Text] [Related]
22. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
23. Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations.
Ribeiro A; Lima S; Zampieri ME; Peinado M; Figueras A
Expert Opin Drug Saf; 2017 Dec; 16(12):1329-1334. PubMed ID: 28817316
[TBL] [Abstract][Full Text] [Related]
24. Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017.
Morales-Ríos O; Cicero-Oneto C; García-Ruiz C; Villanueva-García D; Hernández-Hernández M; Olivar-López V; Jiménez-Juárez RN; Jasso-Gutiérrez L
PLoS One; 2020; 15(3):e0230576. PubMed ID: 32208451
[TBL] [Abstract][Full Text] [Related]
25. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
[TBL] [Abstract][Full Text] [Related]
26. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
Masuka JT; Khoza S
Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
[TBL] [Abstract][Full Text] [Related]
27. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study.
Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X
Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236
[TBL] [Abstract][Full Text] [Related]
28. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
Castillon G; Salvo F; Moride Y
Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
[TBL] [Abstract][Full Text] [Related]
29. Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study.
Monteiro C; Dias B; Vaz-Patto M
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33799926
[TBL] [Abstract][Full Text] [Related]
30. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
[TBL] [Abstract][Full Text] [Related]
31. Drug-related deaths: an analysis of the Italian spontaneous reporting database.
Leone R; Sottosanti L; Luisa Iorio M; Santuccio C; Conforti A; Sabatini V; Moretti U; Venegoni M
Drug Saf; 2008; 31(8):703-13. PubMed ID: 18636789
[TBL] [Abstract][Full Text] [Related]
32. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
[TBL] [Abstract][Full Text] [Related]
33. [Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].
Patrignani A; Palmieri G; Ciampani N; Moretti V; Mariani A; Racca L
G Ital Cardiol (Rome); 2018 Jan; 19(1):54-61. PubMed ID: 29451510
[TBL] [Abstract][Full Text] [Related]
34. Detection of adverse drug reactions through the minimum basic data set.
Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
[TBL] [Abstract][Full Text] [Related]
35. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
36. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
37. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
[TBL] [Abstract][Full Text] [Related]
38. Data mining in pharmacovigilance--detecting the unexpected: the role of index of suspicion of the reporter.
Sundström A; Hallberg P
Drug Saf; 2009; 32(5):419-27. PubMed ID: 19419236
[TBL] [Abstract][Full Text] [Related]
39. The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®.
Matlala MF; Lubbe MS; Steyn H
Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e9. PubMed ID: 36744452
[TBL] [Abstract][Full Text] [Related]
40. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
Oosterhuis I; van Hunsel FP; van Puijenbroek EP
Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
